Rumored Buzz on conolidine
These benefits, together with a preceding report showing that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like conduct in mice,2 support the concept of targeting ACKR3 as a singular solution to modulate the opioid method, which could open up new therapeutic avenues for opioid-similar Problems.Disclaimer: The above is usually a sponsor